Failure of enoxaparin during coronary stenting: a case report.
A 90-year-old male underwent coronary stenting following a bout of coronary insufficiency. Coronary stenting was performed 6 hr following the last dose of low-molecular-weight heparin but was complicated by extensive intrastent clot formation. Low-molecular-weight heparin in the absence of a glycoprotein IIb/IIIa receptor blocker may be insufficient during percutaneous coronary intervention.
Chisholm
Robert J
RJ
Division of Cardiology, St. Michael's Hospital, University of Toronto, Toronto, Canada. chisholm@smh.toronto.on.ca
Cantor
Warren
W
D000369:Aged, 80 and over; D015906:Angioplasty, Balloon, Coronary / Q000295:instrumentation*; D017023:Coronary Angiography; D023903:Coronary Restenosis / Q000139:chemically induced* / Q000000981:diagnostic imaging; D023921:Coronary Stenosis / Q000000981:diagnostic imaging / Q000628:therapy*; D017984:Enoxaparin / Q000009:adverse effects* / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D015607:Stents; D017211:Treatment Failure
D017984:Enoxaparin; D005343:Fibrinolytic Agents